Source: International Congress 2016 – New therapies and therapeutic targets
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cedric Simillion (Bern, Switzerland), Cedric Simillion, Luca Tamo, Remy Bruggmann, Anis Feki, Antje Prasse, Amiq Gazdhar, Thomas Geiser. LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model. Eur Respir J 2016; 48: Suppl. 60, 465

Member's Comments

No comment yet.

Related content which might interest you: Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Therapeutic effects of human perivascular stem cells in an emphysema mouse model Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 3D models of human lung development and disease using pluripotent stem cells Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Modified mesenchymal stem cells attenuate bleomycin induced lung injury in the rat Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Induced pluripotent stem cell derived macrophages differentiate into AM like cells in the lungs of humanized PAP mice Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018